Quarterly ResultMay 11, 2026, 04:11 PM
SI-BONE Q1 Revenue +11.2% to $52.6M; Net Loss Improves 33.8%
AI Summary
SI-BONE, Inc. reported strong first quarter 2026 financial results, with worldwide revenue growing 11.2% to $52.6 million and U.S. revenue increasing 10.0% to $49.3 million. The company significantly improved its financial performance, reducing net loss by 33.8% to $4.3 million and boosting Adjusted EBITDA by over 440% to $2.5 million. Operational highlights included a 17% increase in active U.S. physicians and expanded international presence with new product launches. Reflecting this momentum, SI-BONE raised its full-year 2026 worldwide revenue guidance to a range of $230 million to $233 million and increased its gross margin estimate to approximately 79%.
Key Highlights
- Worldwide revenue grew 11.2% to $52.6 million in Q1 2026.
- U.S. revenue increased 10.0% to $49.3 million.
- Net loss improved 33.8% to $4.3 million, or $0.10 per diluted share.
- Adjusted EBITDA was $2.5 million, an improvement of over 440%.
- Cash and equivalents stood at $144.7 million as of March 31, 2026.
- Active U.S. physicians grew 17% to over 1,650.
- FY2026 worldwide revenue guidance raised to $230 million to $233 million.
- FY2026 gross margin guidance increased to approximately 79%.